| 750458 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer |
2021-10-01 |
10.1136/jitc-2020-002100corr1 |
|
| 750457 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab |
2021-10-01 |
10.1136/jitc-2021-002663 |
Koguchi Yoshinobu, Iwamoto Noriko, Shimada Takashi, Chang Shu-Ching, Cha John, Curti Brendan D, Urba Walter J, Piening Brian D, Redmond William L |
| 750456 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
2021-10-01 |
10.1136/jitc-2020-001694corr1 |
|
| 750455 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition |
2021-10-01 |
10.1136/jitc-2020-001931corr1 |
|
| 750454 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab |
2021-10-01 |
10.1136/jitc-2020-001564corr1 |
|
| 750453 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immunological configuration of ovarian carcinoma: features and impact on disease outcome |
2021-10-01 |
10.1136/jitc-2021-002873 |
Fucikova Jitka, Coosemans An, Orsulic Sandra, Cibula David, Vergote Ignace, Galluzzi Lorenzo, Spisek Radek |
| 750452 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Activation of MAT2A-RIP1 signaling axis reprograms monocytes in gastric cancer |
2021-10-01 |
10.1136/jitc-2020-001364corr2 |
|
| 750451 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model |
2021-10-01 |
10.1136/jitc-2020-001524corr1 |
|
| 750450 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach |
2021-10-01 |
10.1136/jitc-2021-002545corr1 |
|
| 750449 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma |
2021-10-01 |
10.1136/jitc-2021-003521corr1 |
|
